The campaign to change the rules was years in the making, orchestrated in part by two men with close ties to US health secretary RFK Jr ...

Start building your ideal daily routine with Fabulous. The first 100 people who click on the link will get a free week trial ...

NPR's science podcast Short Wave brings us stories on food fortification, why some people don't seem to get the flu, and a study on how much vigorous exercise you really need.

The initial public offering (IPO) market showed signs of life for the first time in more than a month as Boston-based Avalyn Pharma filed a registration statement on Wednesday seeking to raise capital ...

Merck’s MRK stock has risen 51.4% in the past six months. A key driver of the increase is Merck’s improved outlook for long-term growth once its blockbuster drug, Keytruda, loses patent exclusivity.

Health and wellness influencers are hawking unapproved treatments on the gray market. The future of the F.D.A.—and the health ...

On this "Face the Nation with Margaret Brennan" broadcast, Border Czar Tom Homan and former U.S. Surgeon General Jerome Adams ...

IMNN-001 is the first frontline immunotherapy to demonstrate the potential for a clinically meaningful overall survival benefit in women newly ...

This is a collection of local news concisely presented to provide a quick overview of what you might otherwise have missed.

The ouster was first reported by CBS News. A Pentagon official confirmed the report with the Associated Press.

A single-dose of Trogenix's proprietary Synthetic Super-Enhancers achieved complete tumour elimination in 83% of treated cases with no toxicity over 11 months and no tumour recurrence in a brain ...

As opposition mounts in response to the actions of President Donald Trump and his administration, elder Vermonters are ...